mGlu2/3 agonist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mGlu2/3 agonist, covering 2018-11-02 to 2018-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A mGlu2/3 Agonist in the Treatment of PTSD [Phase 1]